Suppr超能文献

Toll 样受体 1 和 10 基因多态性与青少年后细支气管炎哮喘有关。

Toll-like receptor 1 and 10 gene polymorphisms are linked to postbronchiolitis asthma in adolescence.

机构信息

Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland.

Department of Medical Microbiology and Immunology, Turku University, Turku, Finland.

出版信息

Acta Paediatr. 2018 Jan;107(1):134-139. doi: 10.1111/apa.13984. Epub 2017 Aug 8.

Abstract

AIM

Toll-like receptors (TLR) are innate immunity molecules and our previous studies found that TLR1 gene polymorphism was associated with postbronchiolitis asthma at one to six years of age, as was TLR10 at five to seven years of age. This study examined any associations at 11-13 years of age.

METHODS

This prospective follow-up study was part of an ongoing evaluation of children admitted to Tampere University Hospital, Finland, for bronchiolitis in 2001-2004 at less than six months of age. We evaluated the association of TLR1 rs5743618 and TLR10 rs4129009 polymorphisms with asthma and asthma medication in 125 children aged 11-13 years.

RESULTS

Associations were measured as adjusted odd ratios (aOR) with 95% confidence intervals (95% CI). The variant TLR1 rs5743618 (aOR 4.04, 95% CI 0.99-13.01) and TLR10 rs4129009 (aOR 7.02, 95% CI 1.56-31.53) genotypes increased the risk of needing inhaled corticosteroids (ICSs) at 11-13 years of age. The variant TLR10 genotype (aOR 7.69, 95% CI 1.35-43.95) increased the risk of persistent asthma continuing from five to seven years of age until 11-13 years of age. The results were similar when the combined genotypes were analysed. [Correction added on 3 October 2017, after online publication: The data in the variant TRL1 rs5743618 genotype were incorrect and have been corrected in this version.] CONCLUSION: Polymorphisms in both the TLR1 and TLR10 genes may increase the risk of asthma at 11-13 years after infant bronchiolitis.

摘要

目的

Toll 样受体(TLR)是先天免疫分子,我们之前的研究发现,TLR1 基因多态性与一岁至六岁的毛细支气管炎后哮喘有关,TLR10 与五至七岁的哮喘有关。本研究在 11-13 岁时检查了任何关联。

方法

本前瞻性随访研究是芬兰坦佩雷大学医院正在进行的一项评估的一部分,该评估针对 2001-2004 年六个月以下因毛细支气管炎入院的儿童。我们评估了 TLR1 rs5743618 和 TLR10 rs4129009 多态性与 11-13 岁儿童哮喘和哮喘药物的相关性。

结果

关联以调整后的比值比(aOR)及其 95%置信区间(95%CI)进行测量。变体 TLR1 rs5743618(aOR 4.04,95%CI 0.99-13.01)和 TLR10 rs4129009(aOR 7.02,95%CI 1.56-31.53)基因型增加了 11-13 岁需要吸入皮质类固醇(ICS)的风险。变体 TLR10 基因型(aOR 7.69,95%CI 1.35-43.95)增加了从五岁到七岁持续的哮喘到 11-13 岁的风险。当分析组合基因型时,结果相似。[2017 年 10 月 3 日在线出版后更正:变体 TRL1 rs5743618 基因型的数据不正确,此版本已更正。]

结论

婴儿毛细支气管炎后,TLR1 和 TLR10 基因的多态性可能会增加 11-13 岁时哮喘的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验